| Preety Bhatti, MD | |
|
306 Stanaford Rd, Beckley, WV 25801-3142 | |
| (304) 255-3000 | |
| Not Available |
| Full Name | Preety Bhatti |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 23 Years |
| Location | 306 Stanaford Rd, Beckley, West Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316177728 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 25111 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hoboken University Medical Center | Hoboken, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ihpnj Er Llc | 3870963168 | 43 |
News Archive
Researchers at Mayo Clinic were awarded a $6.8 million, five-year federal grant from the National Institutes of Health to develop intelligent devices to track and treat abnormal brain activity in people with epilepsy. The grant, part of a presidential initiative aimed at revolutionizing the understanding of the human brain, is called Brain Research Through Advancing Innovative Neurotechnologies or the BRAIN Initiative.
Bristol-Myers Squibb Company today announced results from the Phase IIb EMERGE clinical trial, in which treatment with the investigational compound PEG-Interferon lambda and ribavirin achieved higher rates of rapid virologic response in genotypes 1, 2, 3, and 4, and complete early virologic response in genotypes 1 and 4 than the standard regimen of PEG-Interferon alfa and ribavirin in treatment-naïve patients chronically infected with hepatitis C.
A stockpiled vaccine designed to fight a strain of avian flu that circulated in 2004 can be combined with a vaccine that matches the current strain of bird flu to protect against a potential pandemic, researchers from Saint Louis University's Center for Vaccine Development have found.
Memorial Hermann Health System and The University of Texas MD Anderson Cancer Center today announced a new partnership to provide a new level of specialized breast screening at a network of community breast care centers in the greater Houston area.
› Verified 7 days ago
| Entity Name | Emergency Associates Of Montclair Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598112146 PECOS PAC ID: 0244522241 Enrollment ID: O20160712002716 |
News Archive
Researchers at Mayo Clinic were awarded a $6.8 million, five-year federal grant from the National Institutes of Health to develop intelligent devices to track and treat abnormal brain activity in people with epilepsy. The grant, part of a presidential initiative aimed at revolutionizing the understanding of the human brain, is called Brain Research Through Advancing Innovative Neurotechnologies or the BRAIN Initiative.
Bristol-Myers Squibb Company today announced results from the Phase IIb EMERGE clinical trial, in which treatment with the investigational compound PEG-Interferon lambda and ribavirin achieved higher rates of rapid virologic response in genotypes 1, 2, 3, and 4, and complete early virologic response in genotypes 1 and 4 than the standard regimen of PEG-Interferon alfa and ribavirin in treatment-naïve patients chronically infected with hepatitis C.
A stockpiled vaccine designed to fight a strain of avian flu that circulated in 2004 can be combined with a vaccine that matches the current strain of bird flu to protect against a potential pandemic, researchers from Saint Louis University's Center for Vaccine Development have found.
Memorial Hermann Health System and The University of Texas MD Anderson Cancer Center today announced a new partnership to provide a new level of specialized breast screening at a network of community breast care centers in the greater Houston area.
› Verified 7 days ago
| Entity Name | Emergency Associates Of St Marys Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477063329 PECOS PAC ID: 4183982663 Enrollment ID: O20171212000887 |
News Archive
Researchers at Mayo Clinic were awarded a $6.8 million, five-year federal grant from the National Institutes of Health to develop intelligent devices to track and treat abnormal brain activity in people with epilepsy. The grant, part of a presidential initiative aimed at revolutionizing the understanding of the human brain, is called Brain Research Through Advancing Innovative Neurotechnologies or the BRAIN Initiative.
Bristol-Myers Squibb Company today announced results from the Phase IIb EMERGE clinical trial, in which treatment with the investigational compound PEG-Interferon lambda and ribavirin achieved higher rates of rapid virologic response in genotypes 1, 2, 3, and 4, and complete early virologic response in genotypes 1 and 4 than the standard regimen of PEG-Interferon alfa and ribavirin in treatment-naïve patients chronically infected with hepatitis C.
A stockpiled vaccine designed to fight a strain of avian flu that circulated in 2004 can be combined with a vaccine that matches the current strain of bird flu to protect against a potential pandemic, researchers from Saint Louis University's Center for Vaccine Development have found.
Memorial Hermann Health System and The University of Texas MD Anderson Cancer Center today announced a new partnership to provide a new level of specialized breast screening at a network of community breast care centers in the greater Houston area.
› Verified 7 days ago
| Entity Name | Ihpnj Er Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225750946 PECOS PAC ID: 3870963168 Enrollment ID: O20230103000314 |
News Archive
Researchers at Mayo Clinic were awarded a $6.8 million, five-year federal grant from the National Institutes of Health to develop intelligent devices to track and treat abnormal brain activity in people with epilepsy. The grant, part of a presidential initiative aimed at revolutionizing the understanding of the human brain, is called Brain Research Through Advancing Innovative Neurotechnologies or the BRAIN Initiative.
Bristol-Myers Squibb Company today announced results from the Phase IIb EMERGE clinical trial, in which treatment with the investigational compound PEG-Interferon lambda and ribavirin achieved higher rates of rapid virologic response in genotypes 1, 2, 3, and 4, and complete early virologic response in genotypes 1 and 4 than the standard regimen of PEG-Interferon alfa and ribavirin in treatment-naïve patients chronically infected with hepatitis C.
A stockpiled vaccine designed to fight a strain of avian flu that circulated in 2004 can be combined with a vaccine that matches the current strain of bird flu to protect against a potential pandemic, researchers from Saint Louis University's Center for Vaccine Development have found.
Memorial Hermann Health System and The University of Texas MD Anderson Cancer Center today announced a new partnership to provide a new level of specialized breast screening at a network of community breast care centers in the greater Houston area.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Preety Bhatti, MD 306 Stanaford Rd, Beckley, WV 25801-3142 Ph: () - | Preety Bhatti, MD 306 Stanaford Rd, Beckley, WV 25801-3142 Ph: (304) 255-3000 |
News Archive
Researchers at Mayo Clinic were awarded a $6.8 million, five-year federal grant from the National Institutes of Health to develop intelligent devices to track and treat abnormal brain activity in people with epilepsy. The grant, part of a presidential initiative aimed at revolutionizing the understanding of the human brain, is called Brain Research Through Advancing Innovative Neurotechnologies or the BRAIN Initiative.
Bristol-Myers Squibb Company today announced results from the Phase IIb EMERGE clinical trial, in which treatment with the investigational compound PEG-Interferon lambda and ribavirin achieved higher rates of rapid virologic response in genotypes 1, 2, 3, and 4, and complete early virologic response in genotypes 1 and 4 than the standard regimen of PEG-Interferon alfa and ribavirin in treatment-naïve patients chronically infected with hepatitis C.
A stockpiled vaccine designed to fight a strain of avian flu that circulated in 2004 can be combined with a vaccine that matches the current strain of bird flu to protect against a potential pandemic, researchers from Saint Louis University's Center for Vaccine Development have found.
Memorial Hermann Health System and The University of Texas MD Anderson Cancer Center today announced a new partnership to provide a new level of specialized breast screening at a network of community breast care centers in the greater Houston area.
› Verified 7 days ago
Dr. Michael Anthony Kelly, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1710 Harper Rd, Beckley, WV 25801 Phone: 304-254-3101 | |
Dr. Fred Patrick Tzystuck Ii, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1710 Harper Rd, Beckley, WV 25801 Phone: 304-254-3101 | |
Dr. Roger Edwards, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 956 N Eisenhower Dr, Beckley, WV 25801 Phone: 681-238-5258 Fax: 681-238-5700 | |
James Stuart Lewis, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 200 Veterans Ave, Beckley, WV 25801 Phone: 304-763-3255 Fax: 304-763-3255 | |
Dr. J. Wayne Mcmillen, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 124 Brookside Lane, Beckley, WV 25801 Phone: 304-255-9205 | |
Dr. Jose S Romero, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1710 Harper Rd, Beckley, WV 25801 Phone: 304-254-3101 |